![](/img/cover-not-exists.png)
Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
Cervantes, A., Elez, E., Roda, D., Ecsedy, J., Macarulla, T., Venkatakrishnan, K., Rosello, S., Andreu, J., Jung, J., Sanchis-Garcia, J. M., Piera, A., Blasco, I., Manos, L., Perez-Fidalgo, J.-A., FinVolume:
18
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-12-0571
Date:
September, 2012
File:
PDF, 1.49 MB
english, 2012